Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Status:
Completed

Trial end date:
2005-10-01

Target enrollment:

Participant gender:

This is an open-label, Phase III study to evaluate the efficacy, safety and PK of MRA in patients with pJIA.

Phase 3

Chugai Pharmaceutical